Lancashire and South Cumbria
Formulary
Formulary
12 Ear, nose and oropharynx
|
12-02-01 Antihistamines
| Azelastine hydrochloride |
|
Formulary
|
Nasal spray 210 microgram per 1 actuation (Azelair®) |
|
| Fluticasone with azelastine |
|
Formulary
|
Third line agent if monotherapy with either intranasal antihistamine or glucocorticoid is not considered sufficient. Consider OTC/Self care. |
 NICE: Allergic rhinitis |
|
| Mometasone furoate with olopatadine Ryaltris® |
|
Formulary
|
Adults and adolescents 12 years of age and older for the treatment of moderate to severe nasal symptoms associated with allergic rhinitis. |
|
Links
- LSCMMG: Antihistamine: Position Statement
LSCMMG: Inflammatory Bowel Disease: High Cost Drugs Commissioning Pathway- LSCMMG: Primary Care Constipation Guidelines
- MHRA: Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review
- NICE CG147: Diverticular disease: diagnosis and management
- NICE CG184 Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE NG1: Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people
- NICE: Allergic rhinitis